Guangzhou Wondfo Biotech Co.,Ltd (300482.SZ)
CNY 23.75
(-0.88%)
CNY 23.75
(-0.88%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 328.67 Million | 1.68 Billion | 664.93 Million | 1.06 Billion | 309.86 Million | 247.6 Million |
| Net Income | 487.42 Million | 1.19 Billion | 632.58 Million | 616.8 Million | 427.09 Million | 346.58 Million |
| Depreciation & Amortization | 277.11 Million | 270.3 Million | 203.63 Million | 139.84 Million | 105.95 Million | 71.94 Million |
| Deferred income taxes | -4.24 Million | 13.31 Million | 2.27 Million | -3.04 Million | -4.66 Million | 582.18 Thousand |
| Stock-based compensation | 9.87 Million | -651.33 Thousand | 43.19 Million | 4.73 Million | 9.93 Million | 11.16 Million |
| Change in working capital | -444.25 Million | 150.41 Million | -248.23 Million | 181.2 Million | -297.41 Million | -175.78 Million |
| Other non-cash items | 21.65 Million | 58.75 Million | 31.47 Million | 122.28 Million | 68.95 Million | 4.85 Million |
| Investing Cash Flow | -113.39 Million | -1.56 Billion | -785.42 Million | -1.02 Billion | -331.84 Million | -210.49 Million |
| Investments in PPE | -432.73 Million | -583.18 Million | -456.48 Million | -419.5 Million | -179.34 Million | -130.88 Million |
| Acquisitions | -10.98 Million | -136.79 Million | 5.4 Million | 200.84 Thousand | -14.73 Million | 1.37 Million |
| Investment purchases | -2.9 Billion | -5.7 Billion | -6.23 Billion | -6.58 Billion | -4.2 Billion | -2.45 Billion |
| Sales/Maturities of investments | 3.23 Billion | 4.87 Billion | 5.89 Billion | 6.01 Billion | 4.07 Billion | 2.37 Billion |
| Other Investing Activities | 330.32 Million | -7.53 Million | 53.7 Thousand | -36.92 Million | -2.03 Million | -1.44 Million |
| Financing Cash Flow | -542.02 Million | 35.33 Million | -270.93 Million | 502.65 Million | -116.38 Million | 631.79 Million |
| Debt repayment | -204.2 Million | -22.8 Million | -90.18 Million | -3 Million | -105.52 Million | -71.6 Million |
| Dividends payments | -220.62 Million | -132.78 Million | -170.78 Million | -85.44 Million | -75.3 Million | -99.61 Million |
| Common Stock Repurchased | -30.1 Million | -41.79 Million | -52.16 Million | -82.14 Million | -34.48 Million | -4.96 Million |
| Common Stock Issuance | - | 41.79 Million | 52.16 Million | 82.14 Million | 34.48 Million | -5.61 Million |
| Other Financing Activities | -104.72 Million | 198.61 Million | -7.01 Million | 595.33 Million | 67.42 Million | 803.01 Million |
| Accounts receivables | -69.64 Million | -137.64 Million | -273.21 Million | -13.49 Million | -222.17 Million | -125.24 Million |
| Accounts payables | -412.31 Million | 296.03 Million | 36.74 Million | 398.26 Million | 7.62 Million | -16.03 Million |
| Inventory | 41.94 Million | -21.28 Million | -14.04 Million | -200.51 Million | -78.2 Million | -35.08 Million |
| Other working capital | 9.87 Million | 13.31 Million | 2.27 Million | -3.04 Million | -4.66 Million | -140.69 Million |
| Cash at beginning of period | 1.16 Billion | 995.21 Million | 1.4 Billion | 878.89 Million | 1.01 Billion | 343.13 Million |
| Cash at end of period | 839.57 Million | 1.16 Billion | 995.21 Million | 1.4 Billion | 878.89 Million | 1.01 Billion |
| Capital Expenditure | -432.73 Million | -583.18 Million | -456.48 Million | -419.5 Million | -179.34 Million | -130.88 Million |
| Effect of forex changes on cash | 5.87 Million | 8.62 Million | -20.24 Million | -8.63 Million | 1.74 Million | 3.47 Million |
| Net cash flow / Change in cash | -320.85 Million | 165.22 Million | -411.67 Million | 527.99 Million | -136.62 Million | 672.38 Million |
| Free Cash Flow | -104.05 Million | 1.09 Billion | 208.44 Million | 642.33 Million | 130.51 Million | 116.72 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | 137.46 Million | 218.33 Million | 87.81 Million | 487.42 Million | 65.3 Million |
| Depreciation & Amortization | - | 67.62 Million | 67.62 Million | 233.41 Million | 277.11 Million | -116.46 Million |
| Deferred income taxes | - | - | - | - | -4.24 Million | 12.14 Million |
| Stock-based compensation | - | 76.3 Thousand | - | 9.87 Million | 9.87 Million | -8.38 Million |
| Change in working capital | - | -333.75 Million | - | -17.81 Million | -444.25 Million | 107.33 Million |
| Other non-cash items | - | 18.17 Million | -99.4 Million | 51.64 Million | 21.65 Million | -1.26 Million |
| Investing Cash Flow | -249.44 Million | -667.94 Million | -482.45 Million | -131.89 Million | -113.39 Million | -332.71 Million |
| Investments in PPE | -102.91 Million | -100.96 Million | -88.49 Million | -138.73 Million | -432.73 Million | -65.52 Million |
| Acquisitions | - | - | - | -10.98 Million | -10.98 Million | 251 Thousand |
| Investment purchases | -1.51 Billion | -1.58 Billion | -954.18 Million | -785.12 Million | -2.9 Billion | -682.21 Million |
| Sales/Maturities of investments | 1.37 Billion | 1.01 Billion | 560.22 Million | 802.15 Million | 3.23 Billion | 415.02 Million |
| Other Investing Activities | - | -566.09 Million | -388.25 Million | 17.82 Million | 330.32 Million | -250.99 Thousand |
| Financing Cash Flow | 149.48 Million | -196.78 Million | 692.08 Million | -123.05 Million | -542.02 Million | -36.45 Million |
| Debt repayment | - | - | - | -3 Million | -204.2 Million | -3 Million |
| Dividends payments | -8.98 Million | -193.88 Million | - | -220.62 Million | -220.62 Million | -5.97 Million |
| Common Stock Repurchased | - | - | - | -30.1 Million | -30.1 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 158.46 Million | -192.53 Million | 692.08 Million | -120.2 Million | -104.72 Million | -30.47 Million |
| Accounts receivables | - | -272.84 Million | - | -69.64 Million | -69.64 Million | 91.57 Million |
| Accounts payables | - | - | - | - | -412.31 Million | 8.38 Million |
| Inventory | - | -60.98 Million | - | 41.94 Million | 41.94 Million | 15.76 Million |
| Other working capital | - | 76.3 Thousand | - | 9.87 Million | 9.87 Million | -8.38 Million |
| Cash at beginning of period | 392.98 Million | 1.17 Billion | 732.82 Million | 732.32 Million | 1.16 Billion | 1.04 Billion |
| Cash at end of period | 263.57 Million | 393.56 Million | 1.17 Billion | 839.57 Million | 839.57 Million | 732.32 Million |
| Capital Expenditure | -102.91 Million | -100.96 Million | -88.49 Million | -138.73 Million | -432.73 Million | -65.52 Million |
| Effect of forex changes on cash | -2.4 Million | -38.66 Thousand | 1.59 Million | -2.73 Million | 5.87 Million | 268.38 Thousand |
| Net cash flow / Change in cash | -129.4 Million | -776.88 Million | 437.62 Million | 107.25 Million | -320.85 Million | -310.21 Million |
| Free Cash Flow | -102.91 Million | -12.94 Million | 30.43 Million | 226.2 Million | -104.05 Million | -6.83 Million |
PIMO
DELPHIFX
010690
7719
CGKEY
SHWGF